Stock Markets February 12, 2026

Baxter Projects 2026 Adjusted EPS Below Street Estimates After Hurricane Disruption

Company flags lingering manufacturing disruptions; fourth-quarter revenue tops expectations while profit misses

By Priya Menon BAX
Baxter Projects 2026 Adjusted EPS Below Street Estimates After Hurricane Disruption
BAX

Baxter signaled that its adjusted earnings per share for fiscal 2026 will land between $1.85 and $2.05, a range below the Wall Street consensus of $2.25. The medical products maker attributed the shortfall to ongoing effects from hurricane-related disruptions at a key manufacturing facility. The stock plunged about 14% in premarket trading after the announcement. In the fourth quarter, adjusted profit from continuing operations was $0.44 per share versus analyst expectations of $0.54, while quarterly revenue of $2.97 billion exceeded estimates of $2.82 billion.

Key Points

  • Baxter's 2026 adjusted earnings per share forecast is $1.85 to $2.05, below the $2.25 consensus; this impacts healthcare and medical-product equities.
  • Fourth-quarter adjusted profit from continuing operations came in at $0.44 per share, below analysts' $0.54 estimate, while revenue of $2.97 billion beat the $2.82 billion estimate.
  • Market reaction was swift, with shares falling roughly 14 percent in premarket trading, reflecting investor concern about ongoing operational disruptions and near-term profitability.

Feb 12 - Baxter said on Thursday that it expects adjusted earnings for 2026 to be in the range of $1.85 to $2.05 per share, a projection that sits noticeably below the average analyst forecast of $2.25 per share compiled by LSEG. The company attributed the shortfall to the continued impact of hurricane-related disruptions at a critical manufacturing unit.

The announcement prompted a sharp market reaction, with Baxter shares tumbling approximately 14 percent in premarket trading following the release of the outlook and quarterly results.

For the fourth quarter, Baxter reported adjusted earnings from continuing operations of $0.44 per share, underperforming the consensus estimate of $0.54 per share. At the same time, quarterly revenue was $2.97 billion, which exceeded analyst expectations of $2.82 billion.

In a statement accompanying the results, the company noted that it achieved sales growth across all of its business segments but that fourth-quarter performance did not meet internal expectations. The company singled out lingering operational impacts tied to a hurricane that disrupted a key manufacturing location as a driver of the weaker-than-anticipated profit trajectory.

The interplay of a revenue beat and an earnings miss highlights the uneven nature of the quarter: top-line demand held up sufficiently to outpace revenue forecasts, while profit margins or operational constraints linked to the manufacturing disruption reduced adjusted earnings from continuing operations versus analyst models.

Separately, the company and market commentary referenced tools that evaluate the stock. One such tool, ProPicks AI, reviews thousands of companies monthly across more than 100 financial metrics to generate stock ideas and rank opportunities based on fundamentals, momentum, and valuation. The tool has noted notable past winners such as Super Micro Computer, which returned +185 percent, and AppLovin, which returned +157 percent. ProPicks AI indicated it assesses whether Baxter is included in its strategies or if alternative opportunities in the sector may offer a better risk-reward profile.

Investors and market participants will be watching how long the hurricane-related effects persist at the manufacturing unit and whether the company can convert sales growth into improved adjusted earnings in the periods ahead.


Contextual recap

  • Baxter projects 2026 adjusted EPS of $1.85 to $2.05, below the analysts' average of $2.25.
  • Fourth-quarter adjusted EPS was $0.44, shy of the $0.54 consensus; quarterly revenue was $2.97 billion, above the $2.82 billion estimate.
  • Management pointed to persistent hurricane-related disruption at a key manufacturing unit as affecting profit outlook.

Risks

  • Persistent operational disruptions at a key manufacturing unit due to hurricane-related damage may continue to suppress profit — this risk primarily affects Baxter and medical-products suppliers.
  • A disconnect between revenue growth and margin recovery introduces uncertainty in earnings conversion, which could affect investor confidence in medical and healthcare equipment stocks.
  • Short-term stock volatility following the profit downgrade may impact shareholders and trading liquidity in Baxter shares.

More from Stock Markets

European Equities Split Between Defense, Financials Rally and Consumer, Healthcare Slump Feb 22, 2026 Stifel Warns Enterprise Software May Face Prolonged Realignment, Drawing Lessons from eCommerce Shift Feb 22, 2026 Chinese AI Stocks Rally as Investors Embrace Winners While U.S. Markets Worry Feb 21, 2026 Three Earnings Reports This Week Will Test the Durability of the AI Investment Theme Feb 21, 2026 Moscow Market Closes Flat as Select Large-Caps Offset Losses Feb 21, 2026